49.55
+3.38(+7.32%)
Currency In USD
| Previous Close | 46.17 |
| Open | 45.79 |
| Day High | 49.73 |
| Day Low | 45.54 |
| 52-Week High | 57.28 |
| 52-Week Low | 20.08 |
| Volume | 703,212 |
| Average Volume | 632,548 |
| Market Cap | 2.04B |
| PE | -16.14 |
| EPS | -3.07 |
| Moving Average 50 Days | 48.94 |
| Moving Average 200 Days | 39.3 |
| Change | 3.38 |
If you invested $1000 in Tarsus Pharmaceuticals, Inc. (TARS) since IPO date, it would be worth $2,407.68 as of March 20, 2025 at a share price of $49.55. Whereas If you bought $1000 worth of Tarsus Pharmaceuticals, Inc. (TARS) shares 3 years ago, it would be worth $2,831.43 as of March 20, 2025 at a share price of $49.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
GlobeNewswire Inc.
Mar 13, 2025 1:49 AM GMT
IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized underwritten public offering of 2,808,988 shares of its common stock at a public of
Tarsus Announces Proposed $100.0 Million Public Offering
GlobeNewswire Inc.
Mar 12, 2025 8:12 PM GMT
IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten public offering of $100.0 million of shares of its common stock. Tarsus a
Tarsus to Participate in Upcoming Investor Conference
GlobeNewswire Inc.
Mar 06, 2025 10:00 PM GMT
IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th, at